IT201900024958A1 - Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate - Google Patents

Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate

Info

Publication number
IT201900024958A1
IT201900024958A1 IT102019000024958A IT201900024958A IT201900024958A1 IT 201900024958 A1 IT201900024958 A1 IT 201900024958A1 IT 102019000024958 A IT102019000024958 A IT 102019000024958A IT 201900024958 A IT201900024958 A IT 201900024958A IT 201900024958 A1 IT201900024958 A1 IT 201900024958A1
Authority
IT
Italy
Prior art keywords
prevention
treatment
protection
composition
gastrointestinal mucosa
Prior art date
Application number
IT102019000024958A
Other languages
English (en)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102019000024958A priority Critical patent/IT201900024958A1/it
Priority to PCT/IB2020/062275 priority patent/WO2021124306A1/en
Priority to EP20841775.8A priority patent/EP4081224A1/en
Publication of IT201900024958A1 publication Critical patent/IT201900024958A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/33Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1664Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
IT102019000024958A 2019-12-20 2019-12-20 Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate IT201900024958A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102019000024958A IT201900024958A1 (it) 2019-12-20 2019-12-20 Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate
PCT/IB2020/062275 WO2021124306A1 (en) 2019-12-20 2020-12-21 Composition for the protection of the gastrointestinal mucosa and for the prevention and treatment of diseases associated therewith
EP20841775.8A EP4081224A1 (en) 2019-12-20 2020-12-21 Composition for the protection of the gastrointestinal mucosa and for the prevention and treatment of diseases associated therewith

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000024958A IT201900024958A1 (it) 2019-12-20 2019-12-20 Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate

Publications (1)

Publication Number Publication Date
IT201900024958A1 true IT201900024958A1 (it) 2021-06-20

Family

ID=70155184

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000024958A IT201900024958A1 (it) 2019-12-20 2019-12-20 Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate

Country Status (3)

Country Link
EP (1) EP4081224A1 (it)
IT (1) IT201900024958A1 (it)
WO (1) WO2021124306A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100021992A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136689A1 (en) * 2007-05-03 2008-11-13 Vital Food Processors Limited Kiwifruit compositions
EP2208500A1 (en) * 2009-01-16 2010-07-21 Bionap S.r.L. Compositions for the treatment of gerd (gastroesophageal reflux disease)
EP2545925A1 (en) * 2011-07-12 2013-01-16 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
EP3124048A1 (en) * 2015-07-30 2017-02-01 Neilos S.r.l. Composition for oral use in the treatment of gastro-oesophageal reflux disease or discomfort
WO2017055909A1 (en) * 2015-10-01 2017-04-06 Apharm S.R.L. Combination of glycosaminoglycans and an antacid agent and compositions thereof
WO2019026047A1 (en) * 2017-08-04 2019-02-07 Neilos S.r.l. COMPOSITION FOR USE IN THE PREVENTION AND / OR TREATMENT OF GASTRIAL OR GASTRO-ESOPHAGEAL DISEASES

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136689A1 (en) * 2007-05-03 2008-11-13 Vital Food Processors Limited Kiwifruit compositions
EP2208500A1 (en) * 2009-01-16 2010-07-21 Bionap S.r.L. Compositions for the treatment of gerd (gastroesophageal reflux disease)
EP2545925A1 (en) * 2011-07-12 2013-01-16 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
EP3124048A1 (en) * 2015-07-30 2017-02-01 Neilos S.r.l. Composition for oral use in the treatment of gastro-oesophageal reflux disease or discomfort
WO2017055909A1 (en) * 2015-10-01 2017-04-06 Apharm S.R.L. Combination of glycosaminoglycans and an antacid agent and compositions thereof
WO2019026047A1 (en) * 2017-08-04 2019-02-07 Neilos S.r.l. COMPOSITION FOR USE IN THE PREVENTION AND / OR TREATMENT OF GASTRIAL OR GASTRO-ESOPHAGEAL DISEASES

Also Published As

Publication number Publication date
EP4081224A1 (en) 2022-11-02
WO2021124306A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
CY1123810T1 (el) Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
SMT201600055B (it) Composizione farmaceutica per il trattamento o la prevenzione del glaucoma
MD3209309T2 (ro) Compoziții care conțin tulpini bacteriene
SMT201400071B (it) Composizione e procedimenti per l'inibizione dellavia di jak
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
CY1124907T1 (el) Αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
IL284034A (en) JAK1 pathway inhibitors for the treatment of gastrointestinal disease
JP1638163S (ja) 内視鏡用プロセッサ
IT201700028184A1 (it) Composti e composizioni per il trattamento della fibrosi cistica
IL286421A (en) Aza-benzothiophene and aza-benzofuran compounds against worms
ES2898975R1 (es) Endoscopio
DK3947375T3 (da) Imidazolonylquinolinforbindelser og terapeutiske anvendelser deraf
IT201900024958A1 (it) Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate
EA201170201A1 (ru) Предотвращение и лечение радиационного поражения
IT201700121764A1 (it) Composizione per il trattamento e/o la prevenzione di patologie neurodegenerative.
IT202000000502A1 (it) Composizione per la protezione della mucosa gastrica.
PT3823655T (pt) Composições para o tratamento da vulvodínia
IL307194A (en) Pharmaceutical preparations containing zolmitriptan
DE112021002668A5 (de) Atemschutzmaske
SG11202108949PA (en) Pharmaceutical composition comprising benzimidazole derivative compound
IT201700050442A1 (it) Composizione per la prevenzione del danno intestinale
MA52306A (fr) Agents préventifs et thérapeutiques de la sarcopénie
DK3618806T3 (da) Sammensætning til behandling af aftæ og mundsår
IT201700028127A1 (it) Composti e composizioni per il trattamento della fibrosi cistica
SG10201906474QA (en) Compositions and methods for the treatment of mucositis